BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8950033)

  • 21. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
    Fan J; Liu D; He C; Li X; He F
    J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages.
    Eason S; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):225-40. PubMed ID: 8861714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of stress urinary incontinence by ginsenoside Rh2.
    Chen YH; Lin YN; Chen WC; Hsieh WT; Chen HY
    Am J Chin Med; 2014; 42(4):817-31. PubMed ID: 25004877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ionizing radiation potentiates the induction of nitric oxide synthase by IFN-gamma and/or LPS in murine macrophage cell lines: role of TNF-alpha.
    McKinney LC; Aquilla EM; Coffin D; Wink DA; Vodovotz Y
    J Leukoc Biol; 1998 Oct; 64(4):459-66. PubMed ID: 9766626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells.
    Chen B; Stout R; Campbell WF
    FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):109-20. PubMed ID: 8809546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP analogue as a triggering signal for the induction of nitric oxide synthesis in murine peritoneal macrophages.
    Park YC; Park SJ; Jun CD; Kim GE; Park KI; Kim HD; Park RK; Chung HT
    Cell Immunol; 1997 Jul; 179(1):41-7. PubMed ID: 9259770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line.
    Kepka-Lenhart D; Chen LC; Morris SM
    J Leukoc Biol; 1996 Jun; 59(6):840-6. PubMed ID: 8691069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia.
    Ramanathan M; Giladi A; Leibovich SJ
    Exp Biol Med (Maywood); 2003 Jun; 228(6):697-705. PubMed ID: 12773701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of hydrolyzable tannins from Melastoma dodecandrum Lour. on nitric oxide production by a murine macrophage-like cell line, RAW264.7, activated with lipopolysaccharide and interferon-gamma.
    Ishii R; Saito K; Horie M; Shibano T; Kitanaka S; Amano F
    Biol Pharm Bull; 1999 Jun; 22(6):647-53. PubMed ID: 10408242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin.
    Laskin DL; Heck DE; Gardner CR; Feder LS; Laskin JD
    J Leukoc Biol; 1994 Dec; 56(6):751-8. PubMed ID: 7527831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
    Nakata H; Kikuchi Y; Tode T; Hirata J; Kita T; Ishii K; Kudoh K; Nagata I; Shinomiya N
    Jpn J Cancer Res; 1998 Jul; 89(7):733-40. PubMed ID: 9738980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygonum tinctorium extract suppresses nitric oxide production by activated macrophages through inhibiting inducible nitric oxide synthase expression.
    Ishihara T; Okura T; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Ethnopharmacol; 2000 Sep; 72(1-2):141-50. PubMed ID: 10967465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL, or Bax in C6Bu-1 cells.
    Kim YS; Jin SH; Lee YH; Kim SI; Park JD
    Arch Pharm Res; 1999 Oct; 22(5):448-53. PubMed ID: 10549570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cell granules inhibit macrophage-mediated lysis of mastocytoma cells (P815) and nitric oxide production.
    Dileepan KN; Lorsbach RB; Stechschulte DJ
    J Leukoc Biol; 1993 Apr; 53(4):446-53. PubMed ID: 8482925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production.
    Gao Y; Yang MF; Su YP; Jiang HM; You XJ; Yang YJ; Zhang HL
    J Ethnopharmacol; 2013 May; 147(2):509-16. PubMed ID: 23545455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells.
    Matsuura M; Saito S; Hirai Y; Okamura H
    Eur J Biochem; 2003 Oct; 270(19):4016-25. PubMed ID: 14511384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
    Choi WY; Lim HW; Lim CJ
    J Pharm Pharmacol; 2013 Feb; 65(2):310-6. PubMed ID: 23278699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages.
    Korhonen R; Lahti A; Hämäläinen M; Kankaanranta H; Moilanen E
    Mol Pharmacol; 2002 Sep; 62(3):698-704. PubMed ID: 12181447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.